Investigators developed a mixed nano micelle drug delivery system for simultaneous targeting of HIV-infected CD4+ T cells with two drugs, suberoylanilide hydroxamic acid and phorbol 12-myristate 13-acetate.
[ACS Applied Bio Materials]
Home Newsletters Immunology of Infectious Disease News CXCR4 Targeting Nanoplatform for Transcriptional Activation of Latent HIV-1 Infected T Cells
